Most bought healthcare stocks in Q2 2021
See which Healthcare stocks institutional investors increased the most in Q2 2021, measured as net growth in reported share positions from Q1 2021 into Q2 2021. Notable additions at the top of this list include GILEAD SCIENCES INC (GILD), ZOMEDICA CORP (ZOM), INCYTE CORP (INCY), AGILON HEALTH INC (AGL). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | 13,547,002 | $1.07B | 0 | 7 | 5 | 0 | 14 |
| ZOM | ZOMEDICA CORP | 13,371,960 | $11.12M | 1 | 0 | 0 | 0 | 2 |
| INCY | INCYTE CORP | 8,854,075 | $778.02M | 0 | 2 | 5 | 0 | 7 |
| AGL | AGILON HEALTH INC | 6,199,700 | $244.38M | 1 | 0 | 0 | 0 | 1 |
| MRNA | MODERNA INC | 5,766,181 | $1.54B | 3 | 4 | 1 | 1 | 8 |
| OGN | ORGANON & CO | 4,579,968 | $137.04M | 11 | 0 | 0 | 0 | 11 |
| QSI | QUANTUM-SI INC | 4,048,303 | $49.63M | 1 | 0 | 0 | 0 | 1 |
| SENS | SENSEONICS HOLDINGS INC | 3,958,327 | $17.35M | 0 | 1 | 0 | 0 | 1 |
| IONS | IONIS PHARMACEUTICALS INC | 3,954,174 | $128.34M | 0 | 3 | 2 | 0 | 5 |
| AHCO | ADAPTHEALTH CORP | 2,830,228 | $74.46M | 1 | 0 | 1 | 0 | 2 |
| NVS | NOVARTIS AG-SPONSORED ADR | 2,822,118 | $398.31M | 1 | 5 | 3 | 0 | 12 |
| PFE | PFIZER INC | 2,653,511 | $161.90M | 1 | 7 | 9 | 0 | 20 |
| BFLY | BUTTERFLY NETWORK INC | 2,644,812 | $25.87M | 0 | 1 | 0 | 0 | 2 |
| OCGN | OCUGEN INC | 2,440,756 | $19.60M | 1 | 0 | 0 | 0 | 1 |
| BMY | BRISTOL-MYERS SQUIBB CO | 2,407,533 | $444.88M | 1 | 11 | 8 | 0 | 24 |
| RXRX | RECURSION PHARMACEUTICALS-A | 2,378,675 | $86.82M | 1 | 0 | 0 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,149,064 | $300.12M | 0 | 3 | 4 | 0 | 8 |
| JNJ | JOHNSON & JOHNSON | 2,065,361 | $314.59M | 1 | 6 | 12 | 0 | 26 |
| TDOC | TELADOC HEALTH INC | 1,662,318 | $51.13M | 0 | 6 | 1 | 0 | 7 |
| BEAM | BEAM THERAPEUTICS INC | 1,660,263 | $448.17M | 0 | 1 | 2 | 0 | 3 |
| BSX | BOSTON SCIENTIFIC CORP | 1,647,542 | $178.81M | 0 | 3 | 4 | 0 | 7 |
| LFST | LIFESTANCE HEALTH GROUP INC | 1,516,500 | $42.25M | 2 | 0 | 0 | 0 | 2 |
| DOCS | DOXIMITY INC-CLASS A | 1,500,000 | $87.30M | 2 | 0 | 0 | 0 | 2 |
| MASS | 908 DEVICES INC | 1,381,491 | $43.07M | 0 | 1 | 0 | 0 | 1 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 1,341,396 | $30.54M | 1 | 0 | 0 | 0 | 1 |
| HOLX | HOLOGIC INC | 1,299,261 | $51.70M | 1 | 4 | 2 | 0 | 7 |
| SNY | SANOFI-ADR | 1,246,993 | $286.84M | 0 | 6 | 0 | 2 | 7 |
| OPK | OPKO HEALTH INC | 1,240,983 | $4.98M | 1 | 1 | 0 | 0 | 3 |
| EXAS | EXACT SCIENCES CORP | 1,178,289 | $72.24M | 0 | 4 | 1 | 2 | 5 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,090,250 | $310.60M | 0 | 1 | 2 | 0 | 5 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 1,062,840 | $21.22M | 0 | 8 | 2 | 1 | 11 |
| ABT | ABBOTT LABORATORIES | 997,321 | -$1.88M | 0 | 5 | 4 | 2 | 14 |
| FATE | FATE THERAPEUTICS INC | 968,671 | $117.16M | 1 | 2 | 0 | 1 | 4 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 965,010 | $15.64M | 0 | 1 | 0 | 0 | 1 |
| CTXR | CITIUS PHARMACEUTICALS INC | 909,255 | $4.84M | 0 | 1 | 0 | 0 | 1 |
| ELV | ELEVANCE HEALTH INC | 904,075 | $539.39M | 0 | 4 | 8 | 0 | 14 |
| MLSS | MILESTONE SCIENTIFIC INC | 871,628 | $2.06M | 0 | 1 | 0 | 0 | 1 |
| BDX | BECTON DICKINSON AND CO | 825,647 | $199.11M | 0 | 5 | 9 | 0 | 17 |
| TXG | 10X GENOMICS INC-CLASS A | 805,001 | $208.37M | 1 | 3 | 0 | 1 | 5 |
| PRGO | Perrigo Company PLC | 764,483 | $50.70M | 0 | 2 | 1 | 0 | 3 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | 756,444 | $34.86M | 0 | 2 | 0 | 0 | 2 |
| AKBA | AKEBIA THERAPEUTICS INC | 752,149 | $3.29M | 0 | 1 | 0 | 1 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 733,754 | $50.16M | 0 | 2 | 0 | 1 | 3 |
| SEER | SEER INC | 724,144 | $9.11M | 1 | 1 | 0 | 0 | 2 |
| ZLAB | ZAI LAB LTD-ADR | 714,517 | $164.09M | 0 | 1 | 1 | 1 | 2 |
| ALLO | ALLOGENE THERAPEUTICS INC | 704,399 | $18.37M | 1 | 0 | 1 | 0 | 2 |
| RPTX | REPARE THERAPEUTICS INC | 688,971 | $22.15M | 1 | 1 | 0 | 0 | 2 |
| ASRT | ASSERTIO HOLDINGS INC | 681,585 | $1.06M | 1 | 0 | 0 | 0 | 1 |
| THC | TENET HEALTHCARE CORP | 679,494 | $69.50M | 0 | 1 | 0 | 1 | 1 |
| OSCR | OSCAR HEALTH INC - CLASS A | 674,019 | -$15.42M | 1 | 1 | 0 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q2 2021
What are the most bought Healthcare stocks in Q2 2021?
The most bought healthcare stocks in Q2 2021 are those with the largest increase in reported share counts across institutional investors compared to Q1 2021, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2021?
Among filers in this sector, net additions were largest in companies such as GILEAD SCIENCES INC (GILD), ZOMEDICA CORP (ZOM), INCYTE CORP (INCY), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2021).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.